EUVIMEDEUVIMED entdecken
Fallbericht

CRE26-049: Intrathecal Rituximab for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Case Report and Literature Review

Aashima Gupta, Mina Aiad, Yacoub Faroun

Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)

DOI: 10.6004/jnccn.2025.7149 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Aashima Gupta und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Internal Medicine, St. Luke's University Health Network, Bethlehem, PA.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • 1Department of Internal Medicine, St. Luke's University Health Network, Bethlehem, PA.
  • 2Department of Hematology and Oncology, St. Luke's University Health Network, Bethlehem, PA.

Zitieren

APA

Gupta, A., Aiad, M., & Faroun, Y. (2026). CRE26-049: Intrathecal Rituximab for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Case Report and Literature Review. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7149

Vancouver

Gupta A, Aiad M, Faroun Y. CRE26-049: Intrathecal Rituximab for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Case Report and Literature Review. Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7149

BibTeX
@article{Gupta2026,
  author = {Gupta, Aashima and Aiad, Mina and Faroun, Yacoub},
  title = {CRE26-049: Intrathecal Rituximab for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Case Report and Literature Review},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  volume = {24},
  number = {3.5},
  doi = {10.6004/jnccn.2025.7149}
}
Kostenlos starten →